Experienced in Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)

Dr. Christine M. Eng

Pediatrics | Medical Genetics
1102 Bates Ave, 
Houston, TX 
Accepting New Patients
Experienced in Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
1102 Bates Ave, 
Houston, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Christine Eng is a Pediatrics specialist and a Medical Genetics provider in Houston, Texas. Dr. Eng is rated as an Experienced provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). Her top areas of expertise are Hypotonia, Gaucher Disease Type 1, Micrognathia, and Meier-Gorlin Syndrome. Dr. Eng is currently accepting new patients.

Her clinical research consists of co-authoring 111 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles and participated in 2 clinical trials in the study of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome).

Specialties
Pediatrics
Medical Genetics
Licenses
Clinical Genetics in TX
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Friday Health

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

1102 Bates Ave, Houston, TX 77030

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Enrollment Status: Completed
Publish Date: June 10, 2021
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Weekly and Every Other Week Dosing Regimens of Iduronate-2-Sulfatase Enzyme Replacement Therapy in Patients With MPS II
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Weekly and Every Other Week Dosing Regimens of Iduronate-2-Sulfatase Enzyme Replacement Therapy in Patients With MPS II
Enrollment Status: Completed
Publish Date: June 10, 2021
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
An Open-Label Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Iduronate-2-Sulfatase Enzyme Replacement Therapy
An Open-Label Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Iduronate-2-Sulfatase Enzyme Replacement Therapy
Enrollment Status: Completed
Publish Date: June 10, 2021
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trials

110 Total Publications

The utility of ultra-deep RNA sequencing in Mendelian disorder diagnostics.
The utility of ultra-deep RNA sequencing in Mendelian disorder diagnostics.
Journal: American journal of human genetics
Published: May 07, 2025
Similar Doctors
Experienced in Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
Dr. Paul R. Hillman
Medical Genetics | Pediatrics
Experienced in Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
Dr. Paul R. Hillman
Medical Genetics | Pediatrics

UT Physicians

6410 Fannin St, 
Houston, TX 
 (0.6 miles away)
Languages Spoken:
English, French, Swahili
See accepted insurances
Accepting New Patients

Paul Hillman is a Medical Genetics specialist and a Pediatrics provider in Houston, Texas. Dr. Hillman is rated as an Advanced provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). His top areas of expertise are Smith-Lemli-Opitz Syndrome, Angelman Syndrome, Microcephaly, and Temple Syndrome. Dr. Hillman is currently accepting new patients.

Experienced in Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
Dr. Lisa T. Emrick
Pediatrics | Pediatric Neurology | Neurology
Experienced in Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
Dr. Lisa T. Emrick
Pediatrics | Pediatric Neurology | Neurology
6701 Fannin St, Suite 1560, 
Houston, TX 
 (0.1 miles away)
832-822-4289
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Lisa Emrick is a Pediatrics specialist and a Pediatric Neurologist in Houston, Texas. Dr. Emrick is rated as a Distinguished provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). Her top areas of expertise are MELAS Syndrome, Hypotonia, CACH Syndrome, Cortical Dysplasia, and Gastrostomy. Dr. Emrick is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Eng's expertise for a condition
ConditionClose
    View All 52 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile